Infectious Diseases Symposium 2026

BBV opt-out testing: experiences in NHS England
Dr Rachel Hill-Tout

Registrar case study: Immunoglobulin (Ig) in the treatment of severe invasive group A streptococcal (iGAS) sepsis
Dr Imogen Fordham

Inflammation in infection: how can we harness this for good?
Dr Fergus Hamilton

Microbiotoxicity: a call to arms
Dr Anastasia Theodosiou

The nature, natural history and management of asymptomatic tuberculosis
Professor Robert Wilkinson